Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Bristol-Myers Seeks To Bust Genentech Cancer Drug Patents

7 May 2013
Intellectual Property partners Michael Molano (Palo Alto), Lisa Ferri (New York) and counsel Richard McCormick (New York) are mentioned as representing Bristol-Myers Squib Co. in an article reporting that Bristol-Myers Squibb filed suit in California federal court that two Genentech Inc. patents relating to blood cancer treatment are invalid and that Bristol-Myers Squibb's antibody-producing cancer drugs Erbitux and Yervoy do not infringe those patents.

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.